We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMX
2251
DELISTED
Terminix Global Holdings, Inc.
TMX
$96K ﹤0.01%
2,123
+1,404
+195% +$57.2K
ENJY
2252
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$96K ﹤0.01%
20,722
+17,919
+639% +$133K
BFAM icon
2253
Bright Horizons
BFAM
$3.75B
$95K ﹤0.01%
752
+465
+162% +$64.6K
BTAI icon
2254
BioXcel Therapeutics
BTAI
$36.7M
$95K ﹤0.01%
293
PAR icon
2255
PAR Technology
PAR
$788M
$95K ﹤0.01%
1,811
+1,039
+135% +$62.6K
SAA icon
2256
ProShares Ulta SmallCap600
SAA
$31M
$95K ﹤0.01%
2,917
-14,782
-84% -$477K
SLP icon
2257
Simulations Plus
SLP
$371M
$95K ﹤0.01%
1,999
+286
+17% +$13.5K
UEIC icon
2258
Universal Electronics
UEIC
$67.9M
$95K ﹤0.01%
2,329
+998
+75% +$41.3K
VREX icon
2259
Varex Imaging
VREX
$779M
$95K ﹤0.01%
3,030
+1,667
+122% +$47.3K
WSR
2260
DELISTED
Whitestone REIT
WSR
$95K ﹤0.01%
9,424
+7,145
+314% +$69.6K
VRN
2261
DELISTED
Veren
VRN
$95K ﹤0.01%
17,948
-41,643
-70% -$203K
MTEM
2262
DELISTED
Molecular Templates, Inc.
MTEM
$95K ﹤0.01%
1,613
+1,392
+630% +$104K
BNFT
2263
DELISTED
Benefitfocus, Inc.
BNFT
$95K ﹤0.01%
8,856
+5,282
+148% +$56.7K
INBX
2264
DELISTED
Inhibrx, Inc. Common Stock
INBX
$95K ﹤0.01%
2,168
+1,901
+712% +$76K
AXTA icon
2265
Axalta
AXTA
$7.99B
$94K ﹤0.01%
2,844
-260
-8% -$8.25K
CDZI icon
2266
Cadiz
CDZI
$292M
$94K ﹤0.01%
24,458
+22,678
+1,274% +$123K
INOD icon
2267
Innodata
INOD
$2.09B
$94K ﹤0.01%
15,850
+14,888
+1,548% +$121K
KNSA icon
2268
Kiniksa Pharmaceuticals
KNSA
$5.99B
$94K ﹤0.01%
7,984
+3,510
+78% +$43.1K
SUN icon
2269
Sunoco
SUN
$14.2B
$94K ﹤0.01%
2,308
-878
-28% -$34.8K
MNRL
2270
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$94K ﹤0.01%
4,439
-5,029
-53% -$110K
AHI
2271
DELISTED
Advanced Health Intelligence Ltd
AHI
$94K ﹤0.01%
+4,828
New +$90.7K
CRCT icon
2272
Cricut
CRCT
$1.21B
$93K ﹤0.01%
4,204
-1,799
-30% -$45.7K
CYBR
2273
DELISTED
CyberArk
CYBR
$93K ﹤0.01%
+535
New +$93.8K
EWY icon
2274
iShares MSCI South Korea ETF
EWY
$27.8B
$93K ﹤0.01%
1,184
+1,127
+1,977% +$89.1K
SUPN icon
2275
Supernus Pharmaceuticals
SUPN
$2.81B
$93K ﹤0.01%
3,189
+2,217
+228% +$67.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.